Is Ceftiofur safe for babies and kids?
Context-dependent for kids(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Ceftiofur, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
What is ceftiofur?
The IUPAC name is 2-methylpropyl 2-(4-chloroanilino)-2-oxoacetate.
Also known as: NQWMPQVVQLNBGG-UHFFFAOYSA-N, Oxalic acid, monoamide, N-(4-chlorophenyl)-, isobutyl ester.
- IUPAC name
- 2-methylpropyl 2-(4-chloroanilino)-2-oxoacetate
- CAS number
- 80370-57-6
- Molecular formula
- C19H17N5O7S3
- Molecular weight
- 523.56 g/mol
- SMILES
- CO/N=C(\C(=O)N[C@@H]1C(=O)N2C1SCC(=C2C(=O)O)CSC(=O)C)c1cccs1
- PubChem CID
- 6420884
Risk for babies
Context-dependentPregnancy alters the metabolism and distribution of Ceftiofur, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of Ceftiofur, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
3 regulatory and scientific bodies have classified Ceftiofur. The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| FDA | 2012 | Approved (NADA 140-890); extra-label use restricted in food animals (GFI #209/#213) | |
| EU | 2010 | Annex I — MRL established | |
| WHO | 2019 | 3rd-gen cephalosporin — Critically Important Antimicrobial |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter ceftiofur
- Veterinary Medicine
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Ceftiofur:
-
Amoxicillin-clavulanate (narrower spectrum)
Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.Relative cost: 1.2-2×
-
Enrofloxacin (for susceptible pathogens)
Trade-offs: Non-halogenated; no toxic combustion gases (HCl, dioxins); requires higher loading (40-65% by weight vs 5-15% for halogenated FRs); affects material properties (density, flexibility, processability); cost-effective at scale.Relative cost: 1.2-2×
Frequently asked questions
Why do regulators disagree about ceftiofur?
Ceftiofur has been classified by 3 agencies including FDA, EU, WHO, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Ceftiofur in the baby app
Look up products containing ceftiofur, compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (1)
- —
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →